Holen Sie sich die Stockscreener-App
6.34
1.48%
-0.09
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$6.43
Offen:
$6.38
24-Stunden-Volumen:
331.22K
Relative Volume:
0.10
Marktkapitalisierung:
$2.37B
Einnahmen:
$10.53B
Nettoeinkommen (Verlust:
$-1.23B
KGV:
-1.9532
EPS:
-3.246
Netto-Cashflow:
$949.99M
1W Leistung:
-7.25%
1M Leistung:
+1.36%
6M Leistung:
+18.41%
1J Leistung:
-12.14%
1-Tages-Spanne:
$6.32
$6.47
1-Wochen-Bereich:
$6.32
$6.99
52-Wochen-Spanne:
$4.33
$8.00
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.3312 | 2.40B | 10.53B | -1.23B | 949.99M | -3.246 |
TAK
Takeda Pharmaceutical Co Adr
|
18.25 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.18 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.58 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.10 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Could Bausch Health Companies (TSX:BHC) Lead Healthcare Stocks Higher? - Kalkine Media
Why Bausch Health Companies Inc stock fell yesterday - wealthawesome.com
Bausch Health Stock Under Pressure as Debt, Execution Risk and Investor Caution Weigh on Sentiment - kalkine.ca
Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets - TradingView
Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets - PR Newswire
(Pr)SILIQ® (brodalumab injection) Now Reimbursed Under Alberta's Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis - PR Newswire Canada
What's Going On With Bausch Health Companies Inc Stock Monday? - wealthawesome.com
Bausch Health Companies (TSX:BHC) Becomes A Healthcare Stock Watch - Kalkine Media
Bausch Health Companies Stock Price Forecast. Should You Buy BHC? - StockInvest.us
Bausch Health (TSX:BHC): Why The Story Matters Today? - Kalkine Media
BHC|Bausch Health Companies Inc|Price:6.760|Chg%:-0.070 - TradingKey
Bausch Health (TSX:BHC) Rises 4.99% as Raised Outlook, Debt Progress and Product Expansion Improve Sentiment - kalkine.ca
Bausch Health (TSX:BHC) Extends Solta Aesthetics Reach With Fraxel FTX Launch - Kalkine Media
Bausch Health launches Fraxel FTX laser system in Australia - Investing.com Australia
Bausch Health launches Fraxel FTX laser system in Australia By Investing.com - Investing.com South Africa
Bausch Health Gains as Solta Medical Launches Fraxel FTX Laser System in Australia - marketscreener.com
Bausch Health Makes Fraxel FTX System Available in Australia - marketscreener.com
Bausch Health Companies Inc. Announces Availability Of Solta Medical's Fraxel FTX In Australia - marketscreener.com
Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia - us.acrofan.com
Could Bausch Health (TSX:BHC) Navigate Healthcare Market Consolidation? - Kalkine Media
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners - PR Newswire
Six Students Affected by Skin Conditions Will Receive Up to $10,000 Each - Stock Titan
Bausch Health Cos (NYSE:BHC) Trading Down 4% After Insider Selling - MarketBeat
Can Bausch (BHC) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Bausch (BHC) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Does Bausch Health (TSX:BHC) Have Stronger Quarters Ahead? - Kalkine Media
What is Zacks Research's Estimate for TSE:BHC Q3 Earnings? - MarketBeat
Bausch Health (BHC) insider sells 36,827 shares in plan trade - Stock Titan
Bausch Health Cos (NYSE:BHC) Insider Aimee Lenar Sells 36,827 Shares - MarketBeat
Bausch Health Companies Insider Sold Shares Worth $258,894, According to a Recent SEC Filing - marketscreener.com
FY2026 EPS Estimate for Bausch Health Cos Raised by Analyst - MarketBeat
Why Did Bausch Health (TSX:BHC) Stock Surge 5.93% on 18 August 2026? - kalkine.ca
Bausch Health (NYSE: BHC) officer may sell stock with vested awards listed - Stock Titan
Bausch Health Stock: A Post-Earnings Rally Extends on a Raised Outlook - kalkine.ca
Bausch Health Cos (NYSE:BHC) Trading Up 5.1%Should You Buy? - MarketBeat
Is Bausch Health (TSX:BHC) Ready For Resilient Growth? - Kalkine Media
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners - AOL.com
Bausch Health (BHC) Advances 2.68% as Shares Test Key Resistance at $6.84Leading Diagonal - Vinanet
Bausch Health Companies Inc.: Target Price Consensus and Analysts Recommendations | BVF | CA0717341071 - marketscreener.com
Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism - kalkine.ca
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - AOL.com
Bausch Health Stock Faces Renewed Pressure as Investor Confidence Weakens - kalkine.ca
Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial (NYSE:BHC) - Seeking Alpha
BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.
What Is Fuelling Bausch Health (TSX:BHC) Midcap Interest? - Kalkine Media
Is Bausch Health (TSX:BHC) Finding Sustainable Pharma Momentum? - kalkinemedia.com
Bausch Health Stock Faces Renewed Pressure as -1.70% Decline Signals Cautious Investor Sentiment - kalkine.ca
Bausch Health Stock Climbs 1.49% as Pharmaceutical Portfolio Strength and Debt Reduction Efforts Boost Investor Confidence - kalkine.ca
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring an 18% Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - The Motley Fool
Bausch + Lomb Updates Board, Reaffirms 2026 Guidance - VisionMonday.com
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):